Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing. Horimoto Y, Semba R, Ushigusa T, Kusama H, et al. Breast Cancer 2026;33:820-828.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Horimoto Y, Semba R, Ushigusa T, Kusama H, et al. Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing. Breast Cancer 2026;33:820-828.
PMID: 42149433